Scynexis Share Price Today
(NASDAQ: SCYX)

Name: Scynexis Share Price Today (NASDAQ: SCYX) - Scynexis Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Scynexis share price is $0.99 & ₹86.10 as on 6 Mar 2025, 2.30 'hrs' IST

$0.99

▲

0.05

(5.25%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Scynexis share price in Dollar and Rupees. Guide to invest in Scynexis stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Scynexis, along with analyst recommendations, forecasts, and comprehensive financials.

Scynexis share price movements

Today's Low: $0.93
Today's High: $1.00
$0.99
6.06%
Downside
Day's Volatility :6.99%
Upside
0.99%
52 Weeks Low: $0.90
52 Weeks High: $3.07
$0.99
9.03%
Downside
52 Weeks Volatility :70.66%
Upside
67.75%

Scynexis (SCYX) Returns

Period	Scynexis Inc	Index (Russel 2000)
3 Months	-21.1%	0.0%
6 Months	-29.64%	0.0%
1 Year	-43.54%	0.0%
3 Years	-74.59%	-11.6%

Scynexis (SCYX) Key Statistics

in dollars & INR

Previous Close	$0.9428
Open	$0.93
Today's High	$0.9999
Today's Low	$0.93
Market Capitalization	$36.8M
Today's Volume	$22.5K
52 Week High	$3.07
52 Week Low	$0.9006
Revenue TTM	$8.6M
EBITDA	$-52.4M
Earnings Per Share (EPS)	$-0.76
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-48.42%

How to invest in Scynexis Stock (SCYX) from India?

It is very easy for Indian residents to invest directly in Scynexis from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Scynexis stock in both Indian Rupees (INR) and US Dollars (USD). Search for Scynexis or SCYX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Scynexis or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Scynexis shares which would translate to 0.878 fractional shares of Scynexis as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Scynexis, in just a few clicks!

Returns in Scynexis (SCYX) for Indian investors in Rupees

The Scynexis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Scynexis investment value today

Current value as on today

₹64,244

Returns

₹35,756

(-35.76%)

Returns from Scynexis Stock

₹40,719 (-40.72%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Scynexis (SCYX)

67%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Scynexis Stock from India on INDmoney has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Scynexis

Federated Hermes Inc
7.63%
Kingdon Capital Management LLC
5.90%
Vanguard Group Inc
4.38%
Avidity Partners Management LP
3.24%
AMH Equity Ltd
1.65%
BlackRock Inc
1.12%

Analyst Recommendation on Scynexis

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Scynexis(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Scynexis Stock (SCYX)

What analysts predicted

Upside of 573.4%

Target:

$6.67

Current:

$0.99

Insights on Scynexis Stock (Ticker Symbol: SCYX)

Price Movement
In the last 6 months, SCYX stock has moved down by -29.6%
Decreasing Revenue
Revenue is down for the last 4 quarters, 5.79M → 660.0K (in $), with an average decrease of 44.4% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -14.45M → -2.80M (in $), with an average increase of 414.9% per quarter
SCYX vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 97.0% return, outperforming this stock by 139.9%
SCYX vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 138.2% return, outperforming this stock by 213.8%
Price to Sales
ForSCYX every $1 of sales, investors are willing to pay $5.3, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

SCYX Scynexis Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$257.0K	↑ 0.0%
Net Income	$-12.5M	↓ 50.25%
Net Profit Margin	-4.9K%	↑ 4899.61%

	FY19	Y/Y Change
Revenue	$121.0K	↓ 52.92%
Net Income	$-55.2M	↑ 343.01%
Net Profit Margin	-45.6K%	↓ 40796.57%

	FY20	Y/Y Change
Revenue	$12.1M	↑ 9858.68%
Net Income	$-55.2M	↓ 0.09%
Net Profit Margin	-457.97%	↑ 45189.96%

	FY21	Y/Y Change
Revenue	$13.2M	↑ 9.24%
Net Income	$-32.9M	↓ 40.44%
Net Profit Margin	-249.68%	↑ 208.29%

	FY22	Y/Y Change
Revenue	$5.1M	↓ 61.32%
Net Income	$-62.8M	↑ 91.11%
Net Profit Margin	-1.2K%	↓ 984.05%

	FY23	Y/Y Change
Revenue	$140.1M	↑ 2652.72%
Net Income	$67.0M	↓ 206.74%
Net Profit Margin	47.84%	↑ 1281.57%

	Q2 FY23	Q/Q Change
Revenue	$131.5M	↑ 11533.1%
Net Income	$122.3M	↓ 319.8%
Net Profit Margin	93.01%	↑ 5015.4%

	Q3 FY23	Q/Q Change
Revenue	$1.8M	↓ 98.66%
Net Income	$-1.8M	↓ 101.44%
Net Profit Margin	-99.77%	↓ 192.78%

	Q4 FY23	Q/Q Change
Revenue	$5.8M	↑ 229.19%
Net Income	$-19.6M	↑ 1014.74%
Net Profit Margin	-337.86%	↓ 238.09%

	Q1 FY24	Q/Q Change
Revenue	$1.4M	↓ 76.32%
Net Income	$411.0K	↓ 102.1%
Net Profit Margin	29.93%	↑ 367.79%

	Q2 FY24	Q/Q Change
Revenue	$736.0K	↓ 46.39%
Net Income	$-14.5M	↓ 3617.76%
Net Profit Margin	-2.0K%	↓ 1994.33%

	Q3 FY24	Q/Q Change
Revenue	$660.0K	↓ 10.33%
Net Income	$-2.8M	↓ 80.58%
Net Profit Margin	-425.45%	↑ 1538.95%

	FY18	Y/Y Change
Profit	$257.0K	↑ 0.0%

	FY19	Y/Y Change
Profit	$121.0K	↓ 52.92%

	FY20	Y/Y Change
Profit	$-303.0K	↓ 350.41%

	FY21	Y/Y Change
Profit	$12.9M	↓ 4341.25%

	FY22	Y/Y Change
Profit	$4.5M	↓ 65.27%

	FY23	Y/Y Change
Profit	$124.5M	↑ 2689.98%

	Q2 FY23	Q/Q Change
Profit	$131.0M	↑ 13095.17%

	Q3 FY23	Q/Q Change
Profit	$1.4M	↓ 98.95%

	Q4 FY23	Q/Q Change
Profit	$-9.0M	↓ 752.39%

	Q1 FY24	Q/Q Change
Profit	$1.4M	↓ 115.23%

	Q2 FY24	Q/Q Change
Profit	$736.0K	↓ 46.39%

	Q3 FY24	Q/Q Change
Profit	$660.0K	↓ 10.33%

	FY18	Y/Y Change
Operating Cash Flow	$-28.3M	↑ 15.34%
Investing Cash Flow	$-803.0K	↓ 91.65%
Financing Cash Flow	$29.4M	↑ 194.56%

	FY19	Y/Y Change
Operating Cash Flow	$-38.1M	↑ 34.59%
Investing Cash Flow	$26.2M	↓ 3367.75%
Financing Cash Flow	$42.3M	↑ 43.78%

	FY20	Y/Y Change
Operating Cash Flow	$-49.4M	↑ 29.47%
Investing Cash Flow	$6.5M	↓ 75.33%
Financing Cash Flow	$94.0M	↑ 122.2%

	FY21	Y/Y Change
Operating Cash Flow	$-54.6M	↑ 10.55%
Investing Cash Flow	$-1.2M	↓ 118.1%
Financing Cash Flow	$67.1M	↓ 28.6%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$74.4M	↓ 493.16%
Investing Cash Flow	$-6.4M	↑ 0.0%
Financing Cash Flow	$-36.6M	↓ 166654.55%

Scynexis Technicals Summary

Sell

Neutral

Buy

Scynexis is currently in a neutral trading position according to technical analysis indicators.

Scynexis (SCYX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Scynexis Inc	-13.9%	-29.64%	-43.54%	-74.59%	-89.4%
Intra-cellular Therapies, Inc.	3.42%	81.22%	98.76%	146.55%	588.92%
Haleon Plc Spon Ads	12.55%	3.39%	28.09%	43.99%	43.99%
Zoetis Inc.	-1.19%	-8.94%	-7.43%	-9.67%	30.97%
Neurocrine Biosciences Inc.	-24.64%	-6.68%	-14.47%	28.61%	27.88%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Scynexis Inc	0.88	NA	0.0	-0.43	-0.48	-0.27	NA	1.54
Intra-cellular Therapies, Inc.	NA	NA	0.0	0.13	-0.09	-0.07	NA	10.81
Haleon Plc Spon Ads	26.68	26.68	1.5	0.36	0.09	0.04	0.02	1.8
Zoetis Inc.	31.17	31.17	3.01	6.07	0.51	0.15	0.01	10.64
Neurocrine Biosciences Inc.	34.8	34.8	0.27	6.47	0.14	0.1	NA	26.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Scynexis Inc	Buy	$36.8M	-89.4%	0.88	0.0%
Intra-cellular Therapies, Inc.	Buy	$14.0B	588.92%	NA	-10.97%
Haleon Plc Spon Ads	Buy	$48.2B	43.99%	26.68	12.84%
Zoetis Inc.	Buy	$76.1B	30.97%	31.17	26.86%
Neurocrine Biosciences Inc.	Buy	$11.3B	27.88%	34.8	14.49%

About Scynexis

SCYNEXIS, Inc., a biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States. It offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, an intravenous drug for the treatment of invasive candidiasis and/or candidemia, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It also develops SCY-247 to treat systemic fungal diseases. The company has licensing and collaboration agreements with GlaxoSmithKline Intellectual Property (No. 3) Limited, Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC for the development, manufacture, and commercialization of ibrexafungerp. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

Organization	Scynexis
Employees	29
CEO	Dr. David Gonzalez Angulo M.D.
Industry	Health Technology

Management People of Scynexis

Name	Title
Dr. David Gonzalez Angulo M.D.	CEO, President & Director
Mr. Ivor Macleod CPA, M.B.A.	Chief Financial Officer
Mr. Scott Sukenick J.D.	Chief Legal Officer & Corporate Secretary
Ms. Daniella Gigante	Vice President of Human Resources & Information Technology

Important FAQs about investing in SCYX Stock from India :

What is Scynexis share price today?

Scynexis share price today stands at $0.99, Open: $0.93 ; Previous Close: $0.94 ; High: $1.00 ; Low: $0.93 ; 52 Week High: $3.07 ; 52 Week Low: $0.90.

The stock opens at $0.93, after a previous close of $0.94. The stock reached a daily high of $1.00 and a low of $0.93, with a 52-week high of $3.07 and a 52-week low of $0.90.

Can Indians buy Scynexis shares?

Yes, Indians can invest in the Scynexis (SCYX) from India.

With INDmoney, you can buy Scynexis at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Scynexis at zero transaction cost.

How can I buy Scynexis shares from India?

It is very easy to buy Scynexis from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Scynexis (SCYX) be purchased?

Yes, you can buy fractional shares of Scynexis with INDmoney app.

What are the documents required to start investing in Scynexis stocks?

To start investing in Scynexis, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.